776 related articles for article (PubMed ID: 10733894)
81. Bacterial expression and refolding of human trypsinogen.
Hohenblum H; Vorauer-Uhl K; Katinger H; Mattanovich D
J Biotechnol; 2004 Apr; 109(1-2):3-11. PubMed ID: 15063609
[TBL] [Abstract][Full Text] [Related]
82. High recovery refolding of rhG-CSF from Escherichia coli, using urea gradient size exclusion chromatography.
Wang C; Wang L; Geng X
Biotechnol Prog; 2008; 24(1):209-13. PubMed ID: 18179225
[TBL] [Abstract][Full Text] [Related]
83. Hydrophobic interaction expanded bed adsorption chromatography (HI-EBAC) based facile purification of recombinant streptokinase from E. coli inclusion bodies.
Goyal D; Sahoo DK; Sahni G
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 850(1-2):384-91. PubMed ID: 17188946
[TBL] [Abstract][Full Text] [Related]
84. Recombinant human retinol-binding protein refolding, native disulfide formation, and characterization.
Xie Y; Lashuel HA; Miroy GJ; Dikler S; Kelly JW
Protein Expr Purif; 1998 Oct; 14(1):31-7. PubMed ID: 9758748
[TBL] [Abstract][Full Text] [Related]
85. Expression and purification of recombinant human granulocyte colony-stimulating factor in fed-batch culture of Escherichia coli.
Kim CK; Choi JH; Lee SB; Lee SM; Oh JW
Appl Biochem Biotechnol; 2014 Mar; 172(5):2425-35. PubMed ID: 24390866
[TBL] [Abstract][Full Text] [Related]
86. Oxidative refolding of recombinant prochymosin.
Wei C; Tang B; Zhang Y; Yang K
Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):345-51. PubMed ID: 10229691
[TBL] [Abstract][Full Text] [Related]
87. Expression, purification, and refolding of a recombinant human bone morphogenetic protein 2 in vitro.
Zhang Y; Ma Y; Yang M; Min S; Yao J; Zhu L
Protein Expr Purif; 2011 Feb; 75(2):155-60. PubMed ID: 20691269
[TBL] [Abstract][Full Text] [Related]
88. Purification and in vitro refolding of maize chloroplast transglutaminase over-expressed in Escherichia coli.
Carvajal-Vallejos PK; Campos A; Fuentes-Prior P; Villalobos E; Almeida AM; Barberà E; Torné JM; Santos M
Biotechnol Lett; 2007 Aug; 29(8):1255-62. PubMed ID: 17479223
[TBL] [Abstract][Full Text] [Related]
89. A simplified bioprocess for human alpha-fetoprotein production from inclusion bodies.
Leong SS; Middelberg AP
Biotechnol Bioeng; 2007 May; 97(1):99-117. PubMed ID: 17115449
[TBL] [Abstract][Full Text] [Related]
90. Integrated refolding techniques for Schistosoma japonicum MTH1 overexpressed as inclusion bodies in Escherichia coli.
Feng Y; Liu L; Wang J; Liu J; Hu W; Wang X; Yang Z
Protein Expr Purif; 2012 Aug; 84(2):181-7. PubMed ID: 22641057
[TBL] [Abstract][Full Text] [Related]
91. Refolding and characterization of rat liver methionine adenosyltransferase from Escherichia coli inclusion bodies.
López-Vara MC; Gasset M; Pajares MA
Protein Expr Purif; 2000 Jul; 19(2):219-26. PubMed ID: 10873534
[TBL] [Abstract][Full Text] [Related]
92. Isolation and renaturation of bio-active proteins expressed in Escherichia coli as inclusion bodies.
Fischer B; Sumner I; Goodenough P
Arzneimittelforschung; 1992 Dec; 42(12):1512-5. PubMed ID: 1288517
[TBL] [Abstract][Full Text] [Related]
93. Catalytic activity of zymomonas mobilis extracellular "levan-levansucrase" complex in sucrose medium.
Bekers M; Upite D; Kaminska E; Laukevics J; Ionina R; Vigants A
Commun Agric Appl Biol Sci; 2003; 68(2 Pt A):321-4. PubMed ID: 15296187
[TBL] [Abstract][Full Text] [Related]
94. One-step on-column purification and refolding of a single-chain variable fragment (scFv) antibody against tumour necrosis factor alpha.
Liu M; Wang X; Yin C; Zhang Z; Lin Q; Zhen Y; Huang H
Biotechnol Appl Biochem; 2006 Mar; 43(Pt 3):137-45. PubMed ID: 16293104
[TBL] [Abstract][Full Text] [Related]
95. Expression, refolding, and characterization of human soluble BAFF synthesized in Escherichia coli.
Cao P; Mei JJ; Diao ZY; Zhang Sq
Protein Expr Purif; 2005 May; 41(1):199-206. PubMed ID: 15802238
[TBL] [Abstract][Full Text] [Related]
96. Improved solubilization of recombinant human growth hormone inclusion body produced in Escherichia coli.
Sonoda H; Sugimura A
Biosci Biotechnol Biochem; 2008 Oct; 72(10):2675-80. PubMed ID: 18838803
[TBL] [Abstract][Full Text] [Related]
97. Production of recombinant serpins in Escherichia coli.
Pearce MC; Cabrita LD
Methods Enzymol; 2011; 501():13-28. PubMed ID: 22078528
[TBL] [Abstract][Full Text] [Related]
98. Construction of a novel cell-surface display system for heterologous gene expression in Escherichia coli by using an outer membrane protein of Zymomonas mobilis as anchor motif.
He MX; Feng H; Zhang YZ
Biotechnol Lett; 2008 Dec; 30(12):2111-7. PubMed ID: 18688577
[TBL] [Abstract][Full Text] [Related]
99. Anti-aggregatory effect of cyclodextrins in the refolding process of recombinant growth hormones from Escherichia coli inclusion bodies.
Bajorunaite E; Cirkovas A; Radzevicius K; Larsen KL; Sereikaite J; Bumelis VA
Int J Biol Macromol; 2009 Jun; 44(5):428-34. PubMed ID: 19428477
[TBL] [Abstract][Full Text] [Related]
100. Expression, purification, renaturation and activation of fish myostatin expressed in Escherichia coli: facilitation of refolding and activity inhibition by myostatin prodomain.
Funkenstein B; Rebhan Y
Protein Expr Purif; 2007 Jul; 54(1):54-65. PubMed ID: 17383894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
